Disease-specific outcome analysis of palliation with the modified Blalock-Taussig shunt

Thierry Bove1, Kristof Vandekerckhove2, Joseph Panzer2

  • 1Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium thierry.bove@ugent.be.

Abstract

Insights

Adverse outcomes after the modified Blalock-Taussig shunt (MBTS) in children are linked to shunt complications, especially in single ventricle hearts. Careful shunt selection and surgical approach are critical for better survival.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Surgery
  • Vascular Surgery

Background:

  • The modified Blalock-Taussig shunt (MBTS) is a common palliative procedure for complex congenital heart defects.
  • Adverse outcomes are frequently reported but often generalized, lacking specific disease correlation.

Purpose of the Study:

  • To analyze the outcomes of MBTS in pediatric patients with various congenital heart disorders.
  • To identify risk factors for mortality and complications following MBTS.

Main Methods:

  • Retrospective analysis of 150 children undergoing MBTS from 1995 to 2013.
  • Outcome assessment included operative mortality, interstage mortality, and survival to shunt takedown.
  • Multivariate analysis was used to identify predictors of shunt-dependent survival.

Main Results:

  • Overall in-hospital mortality was 8.7% and interstage mortality was 5.1%, with 86.1% survival to the next surgery.
  • Shunt-related complications occurred in 18% of patients, including thrombosis, stenosis, and overshunting.
  • Complications in single ventricle hearts (HR 4.10) and increased shunt size-to-weight ratio (HR 2.72) were significant risk factors for mortality.

Conclusions:

  • Shunt-related complications significantly impact MBTS outcomes, particularly in single ventricle physiology.
  • Optimizing shunt size and surgical technique is crucial for improving survival in shunt-dependent patients.